NGS and Germline Testing in Pancreatic Cancer

Panelists discuss how next-generation sequencing (NGS) and germline testing are increasingly being used in pancreatic cancer to identify genetic mutations, guide personalized treatment decisions, and inform the use of targeted therapies, ultimately improving patient outcomes and advancing precision medicine.

EP: 1.Overview of Pancreatic Cancer Treatment Approach

Now Viewing

EP: 2.NGS and Germline Testing in Pancreatic Cancer

EP: 3.Role of Radiation in Pancreatic Cancer Treatment

EP: 4.Treatment Algorithm for Metastatic Pancreatic Cancer

EP: 5.Frontline Setting of Pancreatic Cancer

Recent Videos